Evidence map›Paper›PMID 28603606›Full record

ArticleRSC advances2017

Synthesis and Properties of Magnetic-Optical Core-Shell Nanoparticles.

Elyahb Allie Kwizera, Elise Chaffin, Yongmei Wang, Xiaohua Huang

Abstract read
In one paragraph

Article in RSC advances, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Magnetic Nanoparticle Composites: Synergistic Effects and Applications.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2021
    Review
  11. Article
  12. Multimodal Composite Iron Oxide Nanoparticles for Biomedical Applications.Tissue engineering and regenerative medicine · 2019
    Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Elyahb Allie KwizeraDepartment of Chemistry, The University of Memphis, Memphis, TN 38152.
Elise ChaffinDepartment of Chemistry, The University of Memphis, Memphis, TN 38152.
Yongmei WangDepartment of Chemistry, The University of Memphis, Memphis, TN 38152.
Xiaohua HuangDepartment of Chemistry, The University of Memphis, Memphis, TN 38152.

Funding

Hybrid nanoparticles for capture and detection of circulating tumor cellsR15CA195509 · NCI · UNIVERSITY OF MEMPHIS · PI HUANG, XIAOHUA · 2015 to 2015
$405k
NCI NIH HHS R15 CA195509
6 · The paper itself

Abstract

Due to their high integrity, facile surface chemistry, excellent stability, and dual properties from the core and shell materials, magnetic-plasmonic core-shell nanoparticles are of great interest across a number of science, engineering and biomedical disciplines. They are promising for applications in a broad range of areas including catalysis, energy conversion, biological separation, medical imaging, disease detection and treatment. The technological applications have driven the need for high quality nanoparticles with well controlled magnetic and optical properties. Tremendous progress has been made during past few decades in synthesizing and characterizing magnetic-plasmonic core-shell nanoparticles, mainly iron oxide-gold core-shell nanoparticles. This review introduces various approaches for the synthesis of spherical and anisotropic magnetic-plasmonic core-shell nanoparticles focusing on iron oxide-gold core-shell nanoparticles. Growth mechanisms are discussed to provide understanding of the key factors controlling shape-controlled synthesis. Magnetic and optical properties are summarized from both computational and experimental studies.

Indexed as

core-shell nanoparticlesgoldiron oxidemagnetic-plasmonicoptical propertiesSynthesis

Identifiers

PMID28603606
PMCPMC5460537

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.